Immunoreactivity of p21, MMP-1 and CB2 receptor proteins in cutaneous canine mast cell tumours: an association with the three-tier grading system

Bulak, Kamila; Kycko, Anna; Śmiech, Anna; Łopuszyński, Wojciech

doi:10.2478/jvetres-2023-0066

Abstract

Introduction

Mast cell tumours (MCTs) arise in the dermis and subcutaneous tissues in animals and humans and are one of the most common neoplasms of the skin in dogs. Cannabinoid type 2 receptor (CB2R), cyclin-dependent kinase inhibitor (p21) and matrix metalloproteinase 1 (MMP-1) are potential targets for novel anti-tumour therapeutic strategies. This study evaluated by immunohistochemical means the reactivity of p21, MMP-1 and CB2R proteins in association with a three-tier grading system in cutaneous canine MCTs.

Material and Methods

Formalin-fixed, paraffin-embedded canine MCTs were processed for histochemical analysis and immunohistochemical staining using antibodies against p21, MMP-1 and CB2R. The results were analysed statistically.

Results

The strongest p21 immunolabelling was detected in grade 3 MCTs, while grade 1 tumours showed mild or no detectable p21 immunoreactivity (P-value < 0.001). Strong immunolabelling of MMP-1 was the most common in grade 1 tumours (P-value < 0.001) and CB2R was significantly less frequent in grade 3 tumours than in grade 1 (P-value < 0.001) and grade 2 (P-value < 0.001).

Conclusion

High immunoreactivity of MMP-1 can be a marker of grade 1 MCTs in dogs, whereas p21 protein overexpression can be a marker of grade 3 canine MCTs. Strong CB2R immunoreactivity with simultaneous underexpression of p21 and high immunoreactivity of MMP-1 proteins may indicate that the use of cannabinoids in grade 1 MCTs in dogs is practicable.

References

Al Bitar S., Gali-Muhtasib H.: The Role of the Cyclin Dependent Kinase Inhibitor p21cip1/waf1 in Targeting Cancer: Molecular Mechanisms and Novel Therapeutics. Cancers 2019, 11, 1475, doi: 10.3390/cancers11101475.
Open DOI Search in Google Scholar Back to article
Blackwood L., Murphy S., Buracco P., De Vos J.P., De Fornel-Thibaud P., Hirschberger J., Kessler M., Pastor J., Ponce F., Savary-Bataille K., Argyle D.J.: European consensus document on mast cell tumours in dogs and cats. Vet Comp Oncol 2012, 10, e1–e29, doi: 10.1111/j.1476-5829.2012.00341.x.
Open DOI Search in Google Scholar Back to article
Bonnans C., Chou J., Werb Z.: Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 2014, 15, 786–801, doi: 10.1038/nrm3904.
Open DOI Search in Google Scholar Back to article
Campora L., Miragliotta V., Ricci E., Cristino L., Di Marzo V., Albanese F., Federica Della Valle M., Abramo F.: Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis. Am J Vet Res 2012, 73, 988–995, doi: 10.2460/ajvr.73.7.988.
Open DOI Search in Google Scholar Back to article
Capparelli C., Chiavarina B., Whitaker-Menezes D., Pestell T.G., Pestell R.G., Hulit J., Andò S., Howell A., Martinez-Outschoorn U.E., Sotgia F., Lisanti M.P.: CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis. Cell Cycle 2012, 11, 3599–3610, doi: 10.4161/cc.21884.
Open DOI Search in Google Scholar Back to article
Coussens L.M., Fingleton B., Matrisian L.M.: Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002, 295, 2387–2392, doi: 10.1126/science.1067100.
Open DOI Search in Google Scholar Back to article
Daniel J., Barra C.N., Pulz L.H., Kleeb S.R., Xavier J.G., Catão-Dias J.L., Nishiya A.T., Fukumasu H., Strefezzi R.F.: Intratumoral collagen index predicts mortality and survival in canine cutaneous mast cell tumours. Vet Dermatol 2019, 30, 162–e48, doi: 10.1111/vde.12726.
Open DOI Search in Google Scholar Back to article
De Nardi A.B.D., Horta R.D.S., Fonseca-Alves C.E., Paiva F.N.D., Linhares L.C.M., Firmo B.F., Sueiro F.A.R., Oliveira K.D.D., Lourenço S.V., Strefezzi R.D.F., Brunner C.H.M., Rangel M.M.M., Jark P.C., Castro J.L.C., Ubukata R., Batschinski K., Sobral R.A., Cruz N.O.D., Nishiya A.T., Fernandes S.C., Cunha S.C.D.S., Gerardi D.G., Challoub G.S.G., Biondi L.R., Laufer-Amorim R., Paes P.R.D.O., Lavalle G.E., Huppes R.R., Grandi F., Vasconcellos C.H.D.C., Anjos D.S.D., Luzo Â.C.M., Matera J.M., Vozdova M., Dagli M.L.Z.: Diagnosis, Prognosis and Treatment of Canine Cutaneous and Subcutaneous Mast Cell Tumors. Cells 2022, 11, 1–37, doi: 10.3390/cells11040618.
Open DOI Search in Google Scholar Back to article
Dhopeshwarkar A., Mackie K.: CB2 Cannabinoid receptors as a therapeutic target – what does the future hold? Mol Pharmacol 2014, 86, 430–437, doi: 10.1124/mol.114.094649.
Open DOI Search in Google Scholar Back to article
Di Girolamo N., Wakefield D.: In vitro and in vivo expression of interstitial collagenase/MMP-1 by human mast cells. Dev Immunol 2000, 7, 131–142, doi: 10.1155/2000/82708.
Open DOI Search in Google Scholar Back to article
Galietta V., Parisi F., Cocumelli C., Pierini A., Poli A., Scaramozzino P., Spallucci V., Millanta F.: Preliminary Assessment of Tumor-Associated Tissue Eosinophilia (TATE) in Canine Mast Cell Tumors: Prevalence and Prognostic Relevance and Its Association with Neoangiogenesis. Animals 2023, 13, 283, doi: 10.3390/ani13020283.
Open DOI Search in Google Scholar Back to article
Gartel A.L., Tyner A.L.: The Role of the Cyclin-dependent Kinase Inhibitor p21 in Apoptosis. Mol Cancer Ther 2002, 1, 639–649.
Search in Google Scholar Back to article
Johansson N., Ahonen M., Kähäri V.M.: Matrix metalloproteinases in tumor invasion. Cell Mol Life Sci 2000, 57, 5–15, doi: 10.1007/s000180050495.
Open DOI Search in Google Scholar Back to article
Kim E.M., Jung C.-H., Kim J., Hwang S.-G., Park J.K., Um H.-D.: The p53/p21 Complex Regulates Cancer Cell Invasion and Apoptosis by Targeting Bcl-2 Family Proteins. Cancer Res 2017, 77, 3092–3100, doi: 10.1158/0008-5472.CAN-16-2098.
Open DOI Search in Google Scholar Back to article
Komi D.E.A., Redegeld F.A.: Role of Mast Cells in Shaping the Tumor Microenvironment. Clin Rev Allergy Immunol 2020, 58, 313–325, doi: 10.1007/s12016-019-08753-w.
Open DOI Search in Google Scholar Back to article
Manzoor S., Saif R., Sadia H., Firyal S., Tayyab M., Mansha M., Mahmood A.K., Hashmi A.S., Awan A.R., Wasim M.: Molecular expression of cyclin dependent kinase inhibitor (p21) in canine tumors. J Anim Plant Sci 2019, 29, 1127–1134.
Search in Google Scholar Back to article
Page-McCaw A., Ewald A.J., Werb Z.: Matrix metalloproteinases and the regulation of tissue remodeling. Nat Rev Mol Cell Biol 2007, 8, 221–233, doi: 10.1038/nrm2125.
Open DOI Search in Google Scholar Back to article
Parveen A., Akash M.S., Rehman K., Kyunn W.W.: Dual Role of p21 in the Progression of Cancer and Its Treatment. Crit Rev Eukaryot Gene Expr 2016, 26, 49–62, doi: 10.1615/CritRevEukaryotGeneExpr.v26.i1.60.
Open DOI Search in Google Scholar Back to article
Patnaik A.K., Ehler W.J., MacEwen E.G.: Canine cutaneous mast cell tumor: morphologic grading and survival time in 83 dogs. Vet Pathol 1984, 21, 469–474, doi: 10.1177/030098588402100503.
Open DOI Search in Google Scholar Back to article
Rajamäki M.M., Järvinen A.K., Sorsa T., Maisi P.: Collagenolytic Activity in Bronchoalveolar Lavage Fluid in Canine Pulmonary Eosinophilia. J Vet Intern Med 2002, 16, 658–664, doi: 10.1111/J.1939-1676.2002.TB02404.X.
Open DOI Search in Google Scholar Back to article
Ramer R., Hinz B.: Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1. J Natl Cancer Inst 2008, 100, 59–69, doi: 10.1093/jnci/djm268.
Open DOI Search in Google Scholar Back to article
Ribatti D.: The Staining of Mast Cells: A Historical Overview. Int Arch Allergy Immunol 2018, 176, 55–60, doi: 10.1159/000487538.
Open DOI Search in Google Scholar Back to article
Rinaldi V., Boari A., Ressel L., Bongiovanni L., Crisi P.E., Cabibbo E., Finotello R.: Expression of cannabinoid receptors CB1 and CB2 in canine cutaneous mast cell tumours. Res Vet Sci 2022, 152, 530–536, doi: 10.1016/j.rvsc.2022.09.013.
Open DOI Search in Google Scholar Back to article
Sabattini S., Scarpa F., Berlato D., Bettini G.: Histologic grading of canine mast cell tumor: is 2 better than 3? Vet Pathol 2015, 52, 70–73, doi: 10.1177/0300985814521638.
Open DOI Search in Google Scholar Back to article
Stamenkovic I.: Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003, 200, 448–464, doi: 10.1002/path.1400.
Open DOI Search in Google Scholar Back to article
Theoharides T.C., Alysandratos K.D., Angelidou A., Delivanis D.A., Sismanopoulos N., Zhang B., Asadi S., Vasiadi M., Weng Z., Miniati A., Kalogeromitros D.: Mast cells and inflammation. Biochim Biophys Acta 2012, 1822, 21–33, doi: 10.1016/j.bbadis.2010.12.014.
Open DOI Search in Google Scholar Back to article
Welle M.M., Bley C.R., Howard J., Rüfenacht S.: Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment. Vet Dermatol 2008, 19, 321–339, doi: 10.1111/j.1365-3164.2008.00694.x.
Open DOI Search in Google Scholar Back to article
Willmann M., Hadzijusufovic E., Hermine O., Dacasto M., Marconato L., Bauer K., Peter B., Gamperl S., Eisenwort G., Jensen-Jarolim E., Müller M., Arock M., Vail D.M., Valent P.: Comparative oncology: The paradigmatic example of canine and human mast cell neoplasms. Vet Comp Oncol 2019, 17, 1–10, doi: 10.1111/vco.12440.
Open DOI Search in Google Scholar Back to article
Wu H., Hayashi T., Inoue M.: Immunohistochemical Expression of p27 and p21 in Canine Cutaneous Mast Cell Tumors and Histiocytomas. Vet Path 2004, 41, 296–299, doi: 10.1354/vp.41-3-296.
Open DOI Search in Google Scholar Back to article
Yang Y., Vyawahare R., Lewis-Bakker M., Clarke H.A., Wong A.H.C., Kotra L.P.: Bioactive Chemical Composition of Cannabis Extracts and Cannabinoid Receptors. Molecules 2020, 25, 3466, doi: 10.3390/molecules25153466.
Open DOI Search in Google Scholar Back to article